Caxton Associates (UK)’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Caxton Associates (UK)'s CORT Position: Q3 2026 in Review
Caxton Associates (UK) opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 2,465 shares worth $284K. The stake represents 0.01% of the portfolio and ranks #569 among its holdings.
497 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Caxton Associates (UK) held 2,465 shares of Corcept Therapeutics worth $284K as of Q3 2026.
- Corcept Therapeutics was a new Caxton Associates (UK) position in Q3 2026.
- Corcept Therapeutics made up 0.01% of Caxton Associates (UK)'s portfolio in Q3 2026, its #569 holding.
- 497 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Caxton Associates (UK)'s 13F filing for Q3 2026, filed 13 Nov 2026.